The Hot Stock: Vertex Pharmaceuticals Soars 20%
March 29, 2017 at 17:34 PM EDT
Vertex Pharmaceuticals ( VRTX ) soared to the top of the S&P 500 today after a successful drug trial . Vertex Pharmaceuticals gained 20% to $108.01 today, while the S&P 500 ticked up 0.1% to 2,361.13. Morgan Stanley's Matthew Harrison and team write that the data on Vertex's cystic fibrosis treatment was "as good as we could have hoped." They explain:
